Medical therapy for acute ischemic stroke.

L. B. Goldstein

doi:10.1007/s11883-001-0023-x

Medical therapy for acute ischemic stroke.

L. B. Goldstein

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Over the past decade, there has been an explosion in data related to the treatment of patients with acute ischemic stroke. Thrombolytic therapy with intravenous tissue plasminogen activator has revolutionized the approach to stroke treatment. Intra-arterial administration of thrombolytic agents is also being investigated and is now being used on a compassionate basis. Medical management can have a large impact on stroke-related outcomes, even in patients who do not receive thrombolytic therapy.

Original language	English
Pages (from-to)	299-306
Number of pages	8
Journal	Current Atherosclerosis Reports
Volume	3
Issue number	4
DOIs	https://doi.org/10.1007/s11883-001-0023-x
State	Published - Jul 2001

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s11883-001-0023-x

Cite this

@article{7646e68bcf0344dc9a87cb897178795a,

title = "Medical therapy for acute ischemic stroke.",

abstract = "Over the past decade, there has been an explosion in data related to the treatment of patients with acute ischemic stroke. Thrombolytic therapy with intravenous tissue plasminogen activator has revolutionized the approach to stroke treatment. Intra-arterial administration of thrombolytic agents is also being investigated and is now being used on a compassionate basis. Medical management can have a large impact on stroke-related outcomes, even in patients who do not receive thrombolytic therapy.",

author = "Goldstein, {L. B.}",

year = "2001",

month = jul,

doi = "10.1007/s11883-001-0023-x",

language = "English",

volume = "3",

pages = "299--306",

number = "4",

}

TY - JOUR

T1 - Medical therapy for acute ischemic stroke.

AU - Goldstein, L. B.

PY - 2001/7

Y1 - 2001/7

N2 - Over the past decade, there has been an explosion in data related to the treatment of patients with acute ischemic stroke. Thrombolytic therapy with intravenous tissue plasminogen activator has revolutionized the approach to stroke treatment. Intra-arterial administration of thrombolytic agents is also being investigated and is now being used on a compassionate basis. Medical management can have a large impact on stroke-related outcomes, even in patients who do not receive thrombolytic therapy.

AB - Over the past decade, there has been an explosion in data related to the treatment of patients with acute ischemic stroke. Thrombolytic therapy with intravenous tissue plasminogen activator has revolutionized the approach to stroke treatment. Intra-arterial administration of thrombolytic agents is also being investigated and is now being used on a compassionate basis. Medical management can have a large impact on stroke-related outcomes, even in patients who do not receive thrombolytic therapy.

UR - http://www.scopus.com/inward/record.url?scp=0035403023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035403023&partnerID=8YFLogxK

U2 - 10.1007/s11883-001-0023-x

DO - 10.1007/s11883-001-0023-x

M3 - Review article

C2 - 11389795

AN - SCOPUS:0035403023

SN - 1523-3804

VL - 3

SP - 299

EP - 306

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

IS - 4

ER -

Medical therapy for acute ischemic stroke.

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this